Cancer research benefits from utilising Real-World Data (RWD)
- “COTA is committed to creating a precise, patient-first approach to cancer care through the use of real-world evidence.”
- “Another critical issue that real-world data is beginning to help solve is the lack of diversity in clinical trials…We use real-world data to explore differences in tumour biology. Treatment patterns, and outcomes to further characterise disparities in underrepresented and underserved populations.”
- “Offering the highest quality oncology real-world data from leading academic and community-based cancer centers ensures that everyone touched by cancer has a clear path to the right care.”
Viraj Narayanan, Vice President of Life Sciences COTA inc.
Click here to learn more.
SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.